The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome
Joint Authors
Kumar, Nirmala S.
Carlson, Matthew J.
Yang, Shujie
Dai, Donghai D.
Reyes, Henry D.
Zhang, Yuping
Thiel, Kristina W.
Leslie, Kimberly K.
Source
Obstetrics and Gynecology International
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-10-07
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago.
In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed.
In this review, we explore the estrogen receptor as the most studied biomarker and the best predictor for response for endometrial cancer reported to date.
American Psychological Association (APA)
Leslie, Kimberly K.& Thiel, Kristina W.& Reyes, Henry D.& Yang, Shujie& Zhang, Yuping& Carlson, Matthew J.…[et al.]. 2013. The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome. Obstetrics and Gynecology International،Vol. 2013, no. 2013, pp.1-5.
https://search.emarefa.net/detail/BIM-474824
Modern Language Association (MLA)
Leslie, Kimberly K.…[et al.]. The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome. Obstetrics and Gynecology International No. 2013 (2013), pp.1-5.
https://search.emarefa.net/detail/BIM-474824
American Medical Association (AMA)
Leslie, Kimberly K.& Thiel, Kristina W.& Reyes, Henry D.& Yang, Shujie& Zhang, Yuping& Carlson, Matthew J.…[et al.]. The Estrogen Receptor Joins Other Cancer Biomarkers as a Predictor of Outcome. Obstetrics and Gynecology International. 2013. Vol. 2013, no. 2013, pp.1-5.
https://search.emarefa.net/detail/BIM-474824
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-474824
